← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Pramipexoldihydrochlorid-Monohydrat currently has availability issues reported in 4 European registers: Austria, Germany, Greece, Italy.
Shortage ATC N04BC05 · also listed as: PRAMIPEXOL DIHYDROCHLORID MONOHYDRAT · Pramipexoldihydrochlorid-Monohydrat · PRAMIPEXOLO · data refreshed 11 September 2026
As of 11 September 2026, 4 of the 9 tracked registers list current availability issues for Pramipexoldihydrochlorid-Monohydrat, covering 16 affected product presentations. The longest-running open report was filed in Germany on 2025-03-03 and has now been open for about 18 months. Where agencies state a cause, manufacturing problems lead with 6 of the 12 stated-cause reports, followed by delivery delays with 4. The furthest expected-resolution date currently on file is 2027-01-31; the earliest is 2026-09-30. Notably, 4 reports have already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Momentum is current, not historical: 6 of the open reports were filed within the last 90 days. The issue spread across registers over time rather than at once: Germany reported first (2025-03-03), with Greece following roughly 13 months later — a pattern typical of supply problems cascading between national markets. Registers in Germany, Greece, Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Pramipexoldihydrochlorid-Monohydrat is coded N04BC05 — a medicine acting on the nervous system — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇦🇹 Austria | Shortage Pramipexol Actavis 0,088 mg Tabletten + 4 more productsPramipexol Actavis 0,18 mg Tabletten Pramipexol Actavis 0,35 mg Tabletten Pramipexol Actavis 0,7 mg Tabletten Pramipexol Sandoz 3,15 mg - Retardtabletten | 2026-04-03 | — | — | register ↗ |
| 🇩🇪 Germany | Shortage Pramipexol - 1 A Pharma 0,26 mg Retardtabletten + 1 more productsPramipexol Aurobindo 0,18 mg Tabletten | 2025-03-03 | 2026-09-30 | Sonstige Alternatives: Pramipexol - 1 A Pharma 0,26 mg Retardtabletten - Einreichungsnummer: 2190750 | register ↗ |
| 🇬🇷 Greece | Limited availability GLEPARK TABLET 0,18MG/TAB BTx100 + 3 more productsGLEPARK TABLET 0,18MG/TAB BTx30 GLEPARK TABLET 0,7MG/TAB BTx100 GLEPARK TABLET 0,7MG/TAB BTx30 | 2026-04-30 | 2026-07-30 | BENNETT ΦΑΡΜΑΚΕΥΤΙΚΗ Α.Ε. Καθυστέρηση παράδοσης περιεκτικότητας Alternatives: Εναλλακτικά άλλα σκευάσματα της ίδιας δραστικής, μορφής και | register ↗ |
| 🇮🇹 Italy | Shortage PRAMIPEXOLO AUROBINDO + 6 more productsPRAMIPEXOLO MYLAN PRAMIPEXOLO MYLAN PRAMIPEXOLO MYLAN PHARMA PRAMIPEXOLO MYLAN PHARMA PRAMIPEXOLO PENSA PRAMIPEXOLO TEVA ITALIA | 2025-08-01 | 2027-01-31 | Problemi produttivi Alternatives: AIFA: equivalents with the same active substance are available. | register ↗ |
Every individual register entry for Pramipexoldihydrochlorid-Monohydrat in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇮🇹 IT | PRAMIPEXOLO TEVA ITALIA | Shortage | 2026-09-01 | 2027-01-31 | Elevata richiesta (carenza relativa solo al canale ospedalie |
| 🇮🇹 IT | PRAMIPEXOLO MYLAN PHARMA | Shortage | 2026-08-01 | — | Elevata richiesta |
| 🇩🇪 DE | Pramipexol Aurobindo 0,18 mg Tabletten | Shortage | 2026-07-20 | 2026-09-30 | Probleme in der Herstellung |
| 🇦🇹 AT | Pramipexol Actavis 0,7 mg Tabletten | Resolved | 2026-07-14 | — | |
| 🇦🇹 AT | Pramipexol Sandoz 3,15 mg - Retardtabletten | Shortage | 2026-07-02 | — | |
| 🇦🇹 AT | Pramipexol Actavis 0,35 mg Tabletten | Shortage | 2026-06-18 | — | |
| 🇮🇹 IT | PRAMIPEXOLO AUROBINDO | Shortage | 2026-06-18 | — | Problemi produttivi |
| 🇦🇹 AT | Pramipexol Actavis 0,088 mg Tabletten | Resolved | 2026-05-29 | — | |
| 🇬🇷 GR | GLEPARK TABLET 0,18MG/TAB BTx100 | Limited availability | 2026-04-30 | 2026-07-30 | BENNETT ΦΑΡΜΑΚΕΥΤΙΚΗ Α.Ε. Καθυστέρηση παράδοσης περιεκτικότη |
| 🇬🇷 GR | GLEPARK TABLET 0,18MG/TAB BTx30 | Limited availability | 2026-04-30 | 2026-07-30 | BENNETT ΦΑΡΜΑΚΕΥΤΙΚΗ Α.Ε. Καθυστέρηση παράδοσης περιεκτικότη |
| 🇬🇷 GR | GLEPARK TABLET 0,7MG/TAB BTx100 | Limited availability | 2026-04-30 | 2026-07-30 | BENNETT ΦΑΡΜΑΚΕΥΤΙΚΗ Α.Ε. Καθυστέρηση παράδοσης περιεκτικότη |
| 🇬🇷 GR | GLEPARK TABLET 0,7MG/TAB BTx30 | Limited availability | 2026-04-30 | 2026-07-30 | BENNETT ΦΑΡΜΑΚΕΥΤΙΚΗ Α.Ε. Καθυστέρηση παράδοσης περιεκτικότη |
| 🇦🇹 AT | Pramipexol Actavis 0,18 mg Tabletten | Limited availability | 2026-04-03 | — | |
| 🇮🇹 IT | PRAMIPEXOLO MYLAN | Shortage | 2026-02-19 | — | Problemi produttivi |
| 🇮🇹 IT | PRAMIPEXOLO MYLAN | Shortage | 2025-11-19 | — | Problemi produttivi |
| 🇮🇹 IT | PRAMIPEXOLO PENSA | Shortage | 2025-10-01 | 2026-12-31 | Problemi produttivi |
| 🇮🇹 IT | PRAMIPEXOLO MYLAN PHARMA | Shortage | 2025-08-01 | — | Problemi produttivi |
| 🇩🇪 DE | Pramipexol - 1 A Pharma 0,26 mg Retardtabletten | Shortage | 2025-03-03 | 2026-09-30 | Sonstige |
Yes. As of 11 September 2026, availability issues are reported in: Austria, Germany, Greece, Italy. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-09-30 to 2027-01-31. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
13 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Pramipexoldihydrochlorid-Monohydrat: BASG (Austria), BfArM (Germany), EOF limited-availability list (Greece), AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Pramipexoldihydrochlorid-Monohydrat — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/pramipexoldihydrochlorid-monohydrat/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Pramipexoldihydrochlorid-Monohydrat availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/pramipexoldihydrochlorid-monohydrat/">Pramipexoldihydrochlorid-Monohydrat shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>